Patent Assignment
Reel/Frame 017379/0456
Change of Name
Recorded: 2006-03-29
Pages: 17
Assignor
TANOX PHARMA B.V.
Executed: 2003-11-28
Assignee
PANGENETICS B.V.
YALELAAN 46, 3584 CM UTRECHT, NETHERLANDS
Covered Properties
(2)
Type-1 Ribosome-Inactivating Protein
Patent:
6,680,296 →
Application:
09/445,160 →
Anti-CD40L Immunotoxins for the Treatment of Diseases
Patent:
6,645,494 →
Application:
09/446,351 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 10, 2000
From: STIRPE, FIORENZO; BOLOGNESI, ANDREA
To: TANOX PHARMA B.V.
Reel/Frame 010677/0314 →
Assignment of Assignor's Interest
May 12, 2000
From: BOER DE, MARK; HARTOG DEN, MARCEL TEHODORUS
To: TANOX PHARMA B.V.
Reel/Frame 010838/0565 →
Assignment of Assignor's Interest
Mar 7, 2012
From: PANGENETICS BV
To: PROTODEN TECHNOLOGIES INC.
Reel/Frame 027819/0014 →